Birdwatch Archive

Birdwatch Note

2024-03-24 14:04:05 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

「予防接種後健康被害救済制度」の目的は「因果関係が明らかに否定できないものは、極力救済につなげること」であり、認定自体がワクチンの安全性を否定するものではありません。 https://www.asahi.com/articles/ASRCQ53XCRCPUTFL01H.html 集団免疫に関する記述は事実誤認です。元々、発症予防効果は治験の結果を受けて数値でしめされており、100%の効果を謳ってはいません。また、ワクチンの効果を回避する変異株が出現したことにも留意が必要です。 https://www3.nhk.or.jp/news/special/news_seminar/jiji/jiji72/ また、胎盤移行は新生児の感染防止に役立つことが期待されており、むしろ良いこととみなされています。 https://www.cov19-vaccine.mhlw.go.jp/qa/0078.html

Written by 08C81580C1C5EADE2CF1E37F23E7BF8124C115CAC0D59A0C63E999BE721BF989
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1771815507693597082

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1771900797267398744
  • noteId - 1771900797267398744
  • participantId -
  • noteAuthorParticipantId - 08C81580C1C5EADE2CF1E37F23E7BF8124C115CAC0D59A0C63E999BE721BF989 Participant Details
  • createdAtMillis - 1711289045050
  • tweetId - 1771815507693597082
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • 「予防接種後健康被害救済制度」の目的は「因果関係が明らかに否定できないものは、極力救済につなげること」であり、認定自体がワクチンの安全性を否定するものではありません。 https://www.asahi.com/articles/ASRCQ53XCRCPUTFL01H.html 集団免疫に関する記述は事実誤認です。元々、発症予防効果は治験の結果を受けて数値でしめされており、100%の効果を謳ってはいません。また、ワクチンの効果を回避する変異株が出現したことにも留意が必要です。 https://www3.nhk.or.jp/news/special/news_seminar/jiji/jiji72/ また、胎盤移行は新生児の感染防止に役立つことが期待されており、むしろ良いこととみなされています。 https://www.cov19-vaccine.mhlw.go.jp/qa/0078.html

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-03-24 14:04:05 UTC
(1711289045050)
2024-03-24 20:34:45 UTC
(1711312485102)
CURRENTLY_RATED_HELPFUL 2024-03-25 02:05:07 UTC
(1711332307200)
CURRENTLY_RATED_HELPFUL 2024-03-24 20:34:45 UTC
(1711312485102)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-03-24 19:08:04 -0500 Rating Details
2024-03-24 12:21:41 -0500 Rating Details
2024-03-24 11:48:07 -0500 Rating Details
2024-03-24 11:08:05 -0500 Rating Details
2024-03-24 11:01:22 -0500 Rating Details
2024-03-24 10:18:42 -0500 Rating Details
2024-03-24 09:58:15 -0500 Rating Details
2024-03-24 09:24:48 -0500 Rating Details
2024-03-24 09:13:26 -0500 Rating Details
2024-03-25 20:08:16 -0500 Rating Details
2024-03-25 07:27:41 -0500 Rating Details
2024-03-25 03:23:24 -0500 Rating Details
2024-03-25 03:18:56 -0500 Rating Details
2024-03-25 03:13:33 -0500 Rating Details
2024-03-25 03:05:53 -0500 Rating Details
2024-03-25 03:05:16 -0500 Rating Details
2024-03-25 02:47:16 -0500 Rating Details
2024-03-25 02:29:10 -0500 Rating Details
2024-03-25 02:28:47 -0500 Rating Details
2024-03-25 00:09:14 -0500 Rating Details
2024-03-24 21:02:03 -0500 Rating Details
2024-03-24 17:17:06 -0500 Rating Details
2024-03-24 14:03:31 -0500 Rating Details
2024-03-24 11:58:13 -0500 Rating Details
2024-03-24 11:38:27 -0500 Rating Details
2024-03-24 11:37:12 -0500 Rating Details
2024-03-24 11:27:08 -0500 Rating Details
2024-03-24 10:33:24 -0500 Rating Details
2024-03-24 10:21:50 -0500 Rating Details
2024-03-24 10:13:29 -0500 Rating Details
2024-03-24 10:10:54 -0500 Rating Details
2024-03-24 10:10:31 -0500 Rating Details
2024-03-24 10:08:26 -0500 Rating Details
2024-03-24 10:08:21 -0500 Rating Details
2024-03-24 09:40:47 -0500 Rating Details
2024-03-24 09:39:49 -0500 Rating Details
2024-03-24 09:39:33 -0500 Rating Details
2024-03-24 09:37:09 -0500 Rating Details
2024-03-24 09:36:00 -0500 Rating Details
2024-03-24 09:16:53 -0500 Rating Details
2024-03-25 09:49:32 -0500 Rating Details
2024-03-25 05:40:11 -0500 Rating Details
2024-03-25 04:09:57 -0500 Rating Details
2024-03-25 02:55:38 -0500 Rating Details
2024-03-25 02:49:50 -0500 Rating Details
2024-03-25 02:44:33 -0500 Rating Details
2024-03-25 02:42:20 -0500 Rating Details
2024-03-25 02:29:04 -0500 Rating Details
2024-03-25 02:27:19 -0500 Rating Details
2024-03-25 02:27:08 -0500 Rating Details
2024-03-25 02:26:52 -0500 Rating Details
2024-03-24 18:24:21 -0500 Rating Details
2024-03-24 14:45:09 -0500 Rating Details
2024-03-24 11:16:42 -0500 Rating Details
2024-03-24 10:48:11 -0500 Rating Details
2024-03-24 10:36:36 -0500 Rating Details
2024-03-24 10:07:01 -0500 Rating Details
2024-03-24 09:59:11 -0500 Rating Details
2024-03-24 09:56:57 -0500 Rating Details
2024-03-24 09:47:26 -0500 Rating Details
2024-03-24 09:37:28 -0500 Rating Details
2024-03-24 09:32:00 -0500 Rating Details
2024-03-24 09:21:24 -0500 Rating Details
2024-03-24 09:14:13 -0500 Rating Details
2024-03-24 09:13:18 -0500 Rating Details
2024-04-05 17:56:05 -0500 Rating Details
2024-06-01 04:40:09 -0500 Rating Details